---
category: news
title: "Poolbeg Pharma PLC Announces AI Programme Yields Novel RSV Drug Targets"
excerpt: "First time AI has been used to identify disease targets in RSVLONDON, UK / ACCESSWIRE / / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF) ('Poolbeg' or the 'Company'), a clinical stage infectious disease"
publishedDateTime: 2022-11-08T06:00:00Z
originalUrl: "https://www.benzinga.com/pressreleases/22/11/ac29607588/poolbeg-pharma-plc-announces-ai-programme-yields-novel-rsv-drug-targets"
webUrl: "https://www.benzinga.com/pressreleases/22/11/ac29607588/poolbeg-pharma-plc-announces-ai-programme-yields-novel-rsv-drug-targets"
ampWebUrl: "https://www.benzinga.com/amp/content/29607588"
cdnAmpWebUrl: "https://www-benzinga-com.cdn.ampproject.org/c/s/www.benzinga.com/amp/content/29607588"
type: article
quality: 37
heat: -1
published: false

provider:
  name: Benzinga.com
  domain: benzinga.com

topics:
  - AI

related:
  - title: "AI program yields multiple novel RSV drug targets"
    excerpt: "Poolbeg Pharma says it has made a breakthrough in its AI program with partner OneThree Biotech for the treatment of RSV."
    publishedDateTime: 2022-11-08T09:11:00Z
    webUrl: "https://www.labiotech.eu/trends-news/ai-program-yields-multiple-novel-rsv-drug-targets/"
    type: article
    provider:
      name: labiotech
      domain: labiotech.eu
    quality: 37
    images:
      - url: "https://www.labiotech.eu/wp-content/uploads/2022/11/shutterstock-1197138601.jpg"
        width: 1000
        height: 667
        isCached: true

secured: "zcqZl+6C9x11/uo8SK2j/k4+z3uDBZa38cfkXal4hmpUloPa5c85MinFcEVgmVNLXoOG22MoAoQbvQ+HiQRYuKsWkECNJuy0Hemosgru1Vj0RbDYeSOrlGy/xpt031ySJmXpjn2/FZOwpYAzEDiq8yEE78CMxsP5vOaE5gtS3HxfhPyiByU9h+iZ4M7LAU2Tk0nLq8JYhyYvMKp5lqCI7k6i+khfwZolo20KQNvpnH/gMBUaSKdxZj9PafQU3gjtZH9+7K/4Ya8U3ql0ofSJoTUbGmdIVlX8ZMsGqGDh33Ixdn60srMW58FVBEJnqLmxErzvNonzo7+mPAtIJahJ8a68pAAE/mUSpV4Ar+CBgyc=;hW5R2Yyjy7jyglZrHkrMrg=="
---

